Cairo – Mubasher: The unaudited financial results of Arab Drug Company showed a 40% year-on-year (YoY) growth in its net profits before taxes, logging EGP 35.56 million during the first three months of fiscal year 2020/2021, compared to EGP 25.39 million.
The company generated EGP 159.14 million in revenue during the July-September period, up from EGP 125.39 million in the year-ago period, according to a bourse disclosure on Sunday.
During FY19/20, the company reported net profits of EGP 93.6 million, compared to EGP 43.1 million a year earlier.
